AK0406: New Long-Acting Influenza Antiviral Approved in China August 18, 2026 by Mathieu Maurice Shanghai Ark Biopharmaceutical Co., Ltd announced today that China’s National Medical Products Administration (NMPA) has cleared the Investigational New Drug (IND) application for AK0406 injection, the company’s first antiviral drug-Fc …
